These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 14582874)

  • 1. Globalization and the pharmaceutical industry revisited.
    Busfield J
    Int J Health Serv; 2003; 33(3):581-605. PubMed ID: 14582874
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Globalization in the pharmaceutical industry, Part II.
    Casadio Tarabusi C; Vickery G
    Int J Health Serv; 1998; 28(2):281-303. PubMed ID: 9595345
    [TBL] [Abstract][Full Text] [Related]  

  • 3. India's pharmaceutical industry: hype or high tech take-off?
    Malhotra P; Lofgren H
    Aust Health Rev; 2004 Nov; 28(2):182-93. PubMed ID: 15527398
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Globalization in the pharmaceutical industry, Part I.
    Casadio Tarabusi C; Vickery G
    Int J Health Serv; 1998; 28(1):67-105. PubMed ID: 9493754
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Decline in economic returns from new drugs raises questions about sustaining innovations.
    Berndt ER; Nass D; Kleinrock M; Aitken M
    Health Aff (Millwood); 2015 Feb; 34(2):245-52. PubMed ID: 25646104
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Introductory overview article: internationalization of the health care industry].
    von Bandemer S; Blank W; Büchel D
    Z Evid Fortbild Qual Gesundhwes; 2011; 105(8):607-15. PubMed ID: 22142884
    [No Abstract]   [Full Text] [Related]  

  • 7. Who's really raising drug prices?
    Zagorin A
    Time; 1999 Mar; 153(9):46-8. PubMed ID: 10346086
    [No Abstract]   [Full Text] [Related]  

  • 8. The impact of generic substitution on the turnover and gross margin of pharmaceutical companies a survey 1 year and 5 years after the introduction of generic substitution in Finland.
    Timonen J; Karttunen P; Bengtström M; Ahonen R
    Health Policy; 2009 Oct; 92(2-3):116-23. PubMed ID: 19346023
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Globalization of the pharmaceutical industry and the growing dependency of developing countries: the case of Turkey.
    Semin S; Güldal D
    Int J Health Serv; 2008; 38(2):379-98. PubMed ID: 18459286
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Trans-Pacific Partnership Provisions in Intellectual Property, Transparency, and Investment Chapters Threaten Access to Medicines in the US and Elsewhere.
    Baker BK
    PLoS Med; 2016 Mar; 13(3):e1001970. PubMed ID: 26954325
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Health and intellectual property rights.
    Correa CM
    Bull World Health Organ; 2001; 79(5):381. PubMed ID: 11417031
    [No Abstract]   [Full Text] [Related]  

  • 12. International experiences of promoting generics use and its implications to China.
    Sun J
    J Evid Based Med; 2013 May; 6(2):74-80. PubMed ID: 23829799
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Are we living in the end of the blockbuster drug era?
    Debnath B; Al-Mawsawi LQ; Neamati N
    Drug News Perspect; 2010 Dec; 23(10):670-84. PubMed ID: 21180653
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Joint 24th Medicines for Europe and 21st International Generic and Biosimilars Association (IGBA) Annual Conference (June 13-15, 2018 - Budapest, Hungary).
    Cross G
    Drugs Today (Barc); 2018 Aug; 54(8):499-505. PubMed ID: 30209444
    [TBL] [Abstract][Full Text] [Related]  

  • 15. International Generic Pharmaceutical Alliance - 12th Annual Conference. Part 2.
    Kuhrt K
    IDrugs; 2009 Dec; 12(12):765-9. PubMed ID: 19943218
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Global Generic Medicines--Health Network Communications' Second Annual Summit.
    Burck B
    IDrugs; 2008 May; 11(5):328-30. PubMed ID: 18465671
    [No Abstract]   [Full Text] [Related]  

  • 17. Predictions and Statistics for the Best-Selling Drugs Globally and in the United States in 2018 and a Look Forward to 2024 Projections.
    Lindsley CW
    ACS Chem Neurosci; 2019 Mar; 10(3):1115. PubMed ID: 30889957
    [No Abstract]   [Full Text] [Related]  

  • 18. The danger of in-kind drug donations to the Global Fund.
    Baker BK; Ombaka E
    Lancet; 2009 Apr; 373(9670):1218-21. PubMed ID: 18848353
    [No Abstract]   [Full Text] [Related]  

  • 19. What can Johnson & Johnson do to remain a giant in the health care industry?
    Carter T
    J Hosp Mark Public Relations; 2002; 14(1):93-103. PubMed ID: 12569997
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The impact of TRIPS on innovation and exports: a case study of the pharmaceutical industry in India.
    Malhotra P
    Indian J Med Ethics; 2008; 5(2):61-5. PubMed ID: 18624153
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.